BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21492187)

  • 1. Pharmacokinetics of oral terbinafine in horses and Greyhound dogs.
    Williams MM; Davis EG; KuKanich B
    J Vet Pharmacol Ther; 2011 Jun; 34(3):232-7. PubMed ID: 21492187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single dose pharmacokinetics of terbinafine in cats.
    Wang A; Ding H; Liu Y; Gao Y; Zeng Z
    J Feline Med Surg; 2012 Aug; 14(8):540-4. PubMed ID: 22403416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of oral terbinafine in adult horses.
    Younkin TJ; Davis EG; Kukanich B
    J Vet Pharmacol Ther; 2017 Aug; 40(4):342-347. PubMed ID: 27885696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terbinafine pharmacokinetics after single dose oral administration in the dog.
    Sakai MR; May ER; Imerman PM; Felz C; Day TA; Carlson SA; Noxon JO
    Vet Dermatol; 2011 Dec; 22(6):528-34. PubMed ID: 21599768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of terbinafine and five known metabolites in children, after oral administration.
    Humbert H; Denouël J; Cabiac MD; Lakhdar H; Sioufi A
    Biopharm Drug Dispos; 1998 Oct; 19(7):417-23. PubMed ID: 9818707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of terbinafine after oral administration of a single dose to Hispaniolan Amazon parrots (Amazona ventralis).
    Evans EE; Emery LC; Cox SK; Souza MJ
    Am J Vet Res; 2013 Jun; 74(6):835-8. PubMed ID: 23718650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and comparative bioavailability of two terbinafine hydrochloride formulations after single-dose administration in Chinese healthy subjects.
    Jiang X; Wang N; Zhang ZJ; Tian Y; Chen Y
    Arzneimittelforschung; 2008; 58(7):363-6. PubMed ID: 18751504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of terbinafine and of its five main metabolites in plasma and urine, following a single oral dose in healthy subjects.
    Humbert H; Cabiac MD; Denouël J; Kirkesseli S
    Biopharm Drug Dispos; 1995 Nov; 16(8):685-94. PubMed ID: 8573687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aqueous humor and plasma concentrations of a compounded 0.2% solution of terbinafine following topical ocular administration to normal equine eyes.
    Clode A; Davis J; Davidson G; Salmon J; Lafevers H; Gilger B
    Vet Ophthalmol; 2011 Jan; 14(1):41-7. PubMed ID: 21199278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites.
    Kovarik JM; Mueller EA; Zehender H; Denouël J; Caplain H; Millerioux L
    Antimicrob Agents Chemother; 1995 Dec; 39(12):2738-41. PubMed ID: 8593011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of terbinafine after single oral dose administration in red-tailed hawks (Buteo jamaicensis).
    Bechert U; Christensen JM; Poppenga R; Fahmy SA; Redig P
    J Avian Med Surg; 2010 Jun; 24(2):122-30. PubMed ID: 20806657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of pioglitazone after multiple oral dose administration in horses.
    Wearn JM; Crisman MV; Davis JL; Geor RJ; Hodgson DR; Suagee JK; Ashraf-Khorassani M; McCutcheon LJ
    J Vet Pharmacol Ther; 2011 Jun; 34(3):252-8. PubMed ID: 21492190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of bioequivalence acceptance criteria. The example of terbinafine.
    Koytchev R; Erenmemisoglu A; van der Meer MJ; Alpan S
    Arzneimittelforschung; 2003; 53(4):289-93. PubMed ID: 12785126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of terbinafine in young children treated for tinea capitis.
    Abdel-Rahman SM; Herron J; Fallon-Friedlander S; Hauffe S; Horowitz A; Rivière GJ
    Pediatr Infect Dis J; 2005 Oct; 24(10):886-91. PubMed ID: 16220086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro-in vivo correlation study for the dermatopharmacokinetics of terbinafine hydrochloride topical cream.
    Saeheng S; Nosoongnoen W; Varothai S; Sathirakul K
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1372-7. PubMed ID: 23057672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-proportional pharmacokinetics of terbinafine and its N-demethylated metabolite in healthy volunteers.
    Kovarik JM; Kirkesseli S; Humbert H; Grass P; Kutz K
    Br J Dermatol; 1992 Feb; 126 Suppl 39():8-13. PubMed ID: 1543677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An investigation of the pharmacokinetics of topical terbinafine (Lamisil) 1% cream.
    Hill S; Thomas R; Smith SG; Finlay AY
    Br J Dermatol; 1992 Oct; 127(4):396-400. PubMed ID: 1419761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of persistence of terbinafine in the hair of normal cats after 14 days of daily therapy.
    Foust AL; Marsella R; Akucewich LH; Kunkle G; Stern A; Moattari S; Szabo NJ
    Vet Dermatol; 2007 Aug; 18(4):246-51. PubMed ID: 17610490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stratum corneum pharmacokinetics of the anti-fungal drug, terbinafine, in a novel topical formulation, for single-dose application in dermatophytoses.
    Kienzler JL; Queille-Roussel C; Mugglestone C; Ortonne JP; Larnier C
    Curr Med Res Opin; 2007 Jun; 23(6):1293-302. PubMed ID: 17559730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of oral amantadine in greyhound dogs.
    Norkus C; Rankin D; Warner M; KuKanich B
    J Vet Pharmacol Ther; 2015 Jun; 38(3):305-8. PubMed ID: 25427541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.